• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Exco InTouch predicts device integration growth across clinical trials, healthcare

Exco InTouch predicts device integration growth across clinical trials, healthcare

April 29, 2015
CenterWatch Staff

Exco InTouch, a provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, has predicted a substantial increase in device integration in clinical trials and real-world programs in 2015 and beyond.

Device integration has proven highly beneficial, in part because it creates a simple interface for medical device readings that are a fundamental part of electronic clinical outcomes assessment (eCOA) data. Additionally, there is a clear market trend to design solutions fully compatible with a multitude of home monitoring devices, all of which are capable of being integrated into eDiaries, via Bluetooth or Near Field Communication, ensuring on-time and highly accurate recording of outcomes. As a consequence, demand for device integration is rising fast.  

The growing use of ePRO data collection, combined with Bluetooth technology being built into many devices, is fast enabling the integration of medical device readings into regular ePRO collection by patients, both in clinical trials and in healthcare settings. Device integration goes far beyond just medical devices though, with a growing market trend fast evolving to utilize and integrate consumer technology (ranging from weighting scales, thermometers and activity trackers) as tools to collect secondary outcomes data. While class I or above medical devices are recommended for primary endpoints, especially in phase IIIa studies, a broad range of medical and consumer technologies are finding application in secondary endpoints across all phases due to the valuable insight they provide into physiological data and patient well-being.

Device integration has multiple benefits. This includes real-time data review, time and cost saving in large projects and ease of use for patients, especially those with mobility issues who no longer have to travel to see HCPs. Moreover, device integration solves the serious problem of data collected through different instruments—in which patients often can report incorrect or subjective information on their well-being and their results. The real-time collection of data removes the need to rely on patients for accurate reporting and delivers objective information.

Tim Davis, CEO of Exco InTouch, said, “Device integration has marked itself out as a highly advantageous innovation that is bringing a range of benefits to patients and HCPs alike. Over the past two years we have seen a trend in incorporation of devices to provide valuable supporting data during both clinical trials and healthcare programs. Device integration has proved its worth as a user friendly asset for improving the accuracy, reliability and quality of patient data and reported outcomes.” 

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing